featured
2023 Top Story in Neurology: Effectiveness of Dual Antiplatelet Therapy vs Alteplase in Patients With Minor Non-disabling Acute Ischemic Stroke
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Palaiodimou L, Sarraj A, Safouris A, et al. Endovascular Treatment for Large-Core Ischaemic Stroke: A Meta-Analysis of Randomised Controlled Clinical Trials. J Neurol Neurosurg Psychiatry. 2023;94(10):781-785.
- Chen HS, Cui Y, Zhou ZH, et al. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial. JAMA. 2023;329(24):2135-2144.
- Khatri P, Kleindorfer DO, Devlin T, et al. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial. JAMA. 2018;320(2):156-166.
- Tabaac B, Dickstein L, Gurnea K, et al. Follow-up Imaging After Thrombolysis: FIAT, A Randomized Trial. J Stroke Cerebrovasc Dis. 2023;32(6):107092.
- Pan Y, Elm JJ, Li H, et al. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. JAMA Neurology. 2019;76(12):1466-1473.
Disclosure statements are available on the authors' profiles: